{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:15:57Z","timestamp":1783142157824,"version":"3.54.6"},"reference-count":25,"publisher":"Japanese Society of Veterinary Science","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1292\/jvms.25-0201","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:12:03Z","timestamp":1778191923000},"page":"925-929","source":"Crossref","is-referenced-by-count":0,"title":["Chemotherapy in a dog with neutropenia and marginal zone lymphoma"],"prefix":"10.1292","volume":"88","author":[{"given":"Keiko","family":"KODAMA","sequence":"first","affiliation":[{"name":"Kodama Animal Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"SUWA","sequence":"additional","affiliation":[{"name":"Suwa Animal Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"TANABE","sequence":"additional","affiliation":[{"name":"Veterinary Pathology Diagnostic Center, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"KODAMA","sequence":"additional","affiliation":[{"name":"Kodama Animal Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Brown MR, Rogers KS. 2001. Neutropenia in dogs and cats: a retrospective study of 261 cases. J Am Anim Hosp Assoc<\/i> 37: 131\u2013139.","DOI":"10.5326\/15473317-37-2-131"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Devine L, Armstrong PJ, Whittemore JC, Sharkey L, Bailiff N, Huang A, Rishniw M. 2017. Presumed primary immune-mediated neutropenia in 35 dogs: a retrospective study. J Small Anim Pract<\/i> 58: 307\u2013313.","DOI":"10.1111\/jsap.12636"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Flood-Knapik KE, Durham AC, Gregor TP, S\u00e1nchez MD, Durney ME, Sorenmo KU. 2013. Clinical, histopathological and immunohistochemical characterization of canine indolent lymphoma. Vet Comp Oncol<\/i> 11: 272\u2013286.","DOI":"10.1111\/j.1476-5829.2011.00317.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fournier Q, Serra JC, Handel I, Lawrence J. 2018. Impact of pretreatment neutrophil count on chemotherapy administration and toxicity in dogs with lymphoma treated with CHOP chemotherapy. J Vet Intern Med<\/i> 32: 384\u2013393.","DOI":"10.1111\/jvim.14895"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Frantz AM, Sarver AL, Ito D, Phang TL, Karimpour-Fard A, Scott MC, Valli VE, Lindblad-Toh K, Burgess KE, Husbands BD, Henson MS, Borgatti A, Kisseberth WC, Hunter LE, Breen M, O\u2019Brien TD, Modiano JF. 2013. Molecular profiling reveals prognostically significant subtypes of canine lymphoma. Vet Pathol<\/i> 50: 693\u2013703.","DOI":"10.1177\/0300985812465325"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Garrett LD, Thamm DH, Chun R, Dudley R, Vail DM. 2002. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med<\/i> 16: 704\u2013709.","DOI":"10.1111\/j.1939-1676.2002.tb02411.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gustafson DL, Bailey DB. 2023. Cancer chemotherapy. pp. 182\u2013208. In: Withrow and MacEwen\u2019s Small Animal Clinical Oncology, 6th ed. (Vail DM, Thamm DH, Liptak JM eds.), Elsevier, St. Louis.","DOI":"10.1016\/B978-0-323-59496-7.00012-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Harvey JW. 2012. Evaluation of erythrocytes. pp. 49\u2013121. In: Veterinary Hematology: A Diagnostic Guide and Color Atlas, 1st ed. (Harvey JW ed.), Saunders, St. Louis.","DOI":"10.1016\/B978-1-4377-0173-9.00004-X"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. LaQuaglia KA, Robertson JB, Lunn KF. 2021. Neutropenia in dogs receiving vincristine for treatment of presumptive immune-mediated thrombocytopenia. J Vet Intern Med<\/i> 35: 226\u2013233.","DOI":"10.1111\/jvim.16029"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. McManus PM, Litwin C, Barber L. 1999. Immune-mediated neutropenia in 2 dogs. J Vet Intern Med<\/i> 13: 372\u2013374.","DOI":"10.1111\/j.1939-1676.1999.tb02196.x"},{"key":"11","unstructured":"11. Nelson RW, Couto CG. 2013. Leukopenia and leukocytosis. pp. 1230\u20131238. In: Small Animal Internal Medicine, 5th ed. (Nelson RW, Couto CG eds.), Elsevier, St. Louis."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Northrup NC, Rassnick KM, Snyder LA, Stone MS, Kristal O, Cotter SM, Moore AS. 2002. Neutropenia associated with vincristine and L-asparaginase induction chemotherapy for canine lymphoma. J Vet Intern Med<\/i> 16: 570\u2013575.","DOI":"10.1111\/j.1939-1676.2002.tb02389.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ponce F, Magnol JP, Ledieu D, Marchal T, Turinelli V, Chalvet-Monfray K, Fournel-Fleury C. 2004. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Vet J<\/i> 167: 158\u2013166.","DOI":"10.1016\/j.tvjl.2003.10.009"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ponce F, Marchal T, Magnol JP, Turinelli V, Ledieu D, Bonnefont C, Pastor M, Delignette ML, Fournel-Fleury C. 2010. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Vet Pathol<\/i> 47: 414\u2013433.","DOI":"10.1177\/0300985810363902"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Richards KL, Motsinger-Reif AA, Chen HW, Fedoriw Y, Fan C, Nielsen DM, Small GW, Thomas R, Smith C, Dave SS, Perou CM, Breen M, Borst LB, Suter SE. 2013. Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL. Cancer Res<\/i> 73: 5029\u20135039.","DOI":"10.1158\/0008-5472.CAN-12-3546"},{"key":"16","unstructured":"16. Schultze A. 2010. Interpretation of canine leukocyte responses. pp. 321\u2013334. In: Schalm\u2019s Veterinary Hematology, 6th ed. (Weiss D, Wardrop K eds.), Blackwell, Ames."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sorenmo KU, Harwood LP, King LG, Drobatz KJ. 2010. Case-control study to evaluate risk factors for the development of sepsis (neutropenia and fever) in dogs receiving chemotherapy. J Am Vet Med Assoc<\/i> 236: 650\u2013656.","DOI":"10.2460\/javma.236.6.650"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Vail DM, Pinkerton M, Young KM. 2023. Hematopoietic Tumors. pp. 688\u2013772. In: Withrow and MacEwen\u2019s Small Animal Clinical Oncology, 6th ed. (Vail DM, Thamm DH, Liptak JM eds.), Elsevier, St. Louis.","DOI":"10.1016\/B978-0-323-59496-7.00033-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Vail DM, Michels GM, Khanna C, Selting KA, London CA. Veterinary Cooperative Oncology Group. 2010. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a Veterinary Cooperative Oncology Group (VCOG) consensus document. Vet Comp Oncol<\/i> 8: 28\u201337.","DOI":"10.1111\/j.1476-5829.2009.00200.x"},{"key":"20","unstructured":"20. Valli VE. 2016. B-Cell neoplasms. pp. 168\u2013189. In: Veterinary Comparative Hematopathology, 1st ed. (Valli VE ed.), Wiley Blackwell, Ames."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Valli VE, Bienzle D, Meuten DJ. 2020. Tumors of the hemolymphatic system. pp. 203\u2013320. In: Tumors in Domestic Animals, 5th ed. (Meuten DJ ed.), Wiley-Blackwell, Hoboken.","DOI":"10.1002\/9781119181200.ch7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Valli VE, Kass PH, San Myint M, Scott F. 2013. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival. Vet Pathol<\/i> 50: 738\u2013748.","DOI":"10.1177\/0300985813478210"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Valli VE, Vernau W, de Lorimier LP, Graham PS, Moore PF. 2006. Canine indolent nodular lymphoma. Vet Pathol<\/i> 43: 241\u2013256.","DOI":"10.1354\/vp.43-3-241"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Vezzali E, Parodi AL, Marcato PS, Bettini G. 2010. Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO. Vet Comp Oncol<\/i> 8: 38\u201349.","DOI":"10.1111\/j.1476-5829.2009.00201.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wang SL, Lee JJ, Liao AT. 2015. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma. Vet J<\/i> 205: 69\u201373.","DOI":"10.1016\/j.tvjl.2015.04.032"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/88\/7\/88_25-0201\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:25:06Z","timestamp":1783139106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/88\/7\/88_25-0201\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.25-0201","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25-0201"}}